Yang Lei

Yang Lei is a seasoned professional in biostatistics with extensive experience in the pharmaceutical industry. Currently serving as Senior Director of Biostatistics at Atea Pharmaceuticals, Inc. since February 2022, Yang previously held the position of Director and Head of Biostatistics at Spero Therapeutics, focusing on infectious diseases. Earlier roles include Associate Director at Biogen, where responsibilities encompassed Real World Evidence Strategy and Analytics in neurology, and Manager of Statistics at AbbVie, managing statistics for various therapeutic areas and clinical trials. Additionally, Yang worked as a Senior Biostatistician at St. Luke's Hospital in Kansas City, specializing in cardiology, and began a career as a Co-op at Wyeth Pharmaceuticals. Academic credentials include a Master's degree in Biostatistics from the University of Iowa and a Ph.D. in Biostatistics from the University of Kansas Medical Center.